Xponance’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.32M | Buy |
25,404
+6,752
| +36% | +$351K | 0.01% | 634 |
|
2025
Q1 | $1.19M | Buy |
18,652
+198
| +1% | +$12.6K | 0.01% | 635 |
|
2024
Q4 | $882K | Buy |
18,454
+1,051
| +6% | +$50.2K | 0.01% | 765 |
|
2024
Q3 | $996K | Sell |
17,403
-359
| -2% | -$20.5K | 0.01% | 703 |
|
2024
Q2 | $930K | Sell |
17,762
-1,101
| -6% | -$57.6K | 0.01% | 693 |
|
2024
Q1 | $767K | Buy |
18,863
+131
| +0.7% | +$5.33K | 0.01% | 797 |
|
2023
Q4 | $692K | Sell |
18,732
-153
| -0.8% | -$5.66K | 0.01% | 814 |
|
2023
Q3 | $721K | Sell |
18,885
-506
| -3% | -$19.3K | 0.01% | 762 |
|
2023
Q2 | $699K | Sell |
19,391
-1,568
| -7% | -$56.6K | 0.01% | 778 |
|
2023
Q1 | $800K | Buy |
20,959
+91
| +0.4% | +$3.48K | 0.01% | 733 |
|
2022
Q4 | $1.19M | Sell |
20,868
-484
| -2% | -$27.5K | 0.02% | 581 |
|
2022
Q3 | $844K | Buy |
21,352
+68
| +0.3% | +$2.69K | 0.02% | 637 |
|
2022
Q2 | $936K | Buy |
21,284
+691
| +3% | +$30.4K | 0.02% | 596 |
|
2022
Q1 | $821K | Sell |
20,593
-14
| -0.1% | -$558 | 0.01% | 672 |
|
2021
Q4 | $829K | Sell |
20,607
-632
| -3% | -$25.4K | 0.01% | 686 |
|
2021
Q3 | $864K | Sell |
21,239
-238
| -1% | -$9.68K | 0.02% | 628 |
|
2021
Q2 | $975K | Buy |
21,477
+7,502
| +54% | +$341K | 0.02% | 608 |
|
2021
Q1 | $583K | Sell |
13,975
-3,065
| -18% | -$128K | 0.01% | 705 |
|
2020
Q4 | $728K | Buy |
+17,040
| New | +$728K | 0.02% | 585 |
|